CC-92480 Plus Dexamethasone Shows Favorable Activity in Relapsed/Refractory Myeloma

CC-92480 in combination with dexamethasone demonstrated favorable activity and safety data in patients with heavily pretreated relapsed or refractory multiple myeloma.

Source: CancerNetwork - June 5, 2020 Category: Cancer & Oncology Authors: Dylann Cohn-Emery Source Type: news